The Effect of Progesterone on Spontaneous and Agonist-Evoked Contractions of the Rat Aorta and Portal Vein

The mechanisms underlying the suppression of vasocontractility caused by progesterone were investigated by studying changes in the contractile force of rat isolated aorta and portal vein, induced by altering extracellular concentrations of noradrenaline (NA) potassium ions (K+) and calcium ions (Ca2...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pharmacy and pharmacology 2000-07, Vol.52 (7), p.843-849
Hauptverfasser: MUKERJI, MARK S., LEATHARD, HELEN L., HUDDART, HENRY
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 849
container_issue 7
container_start_page 843
container_title Journal of pharmacy and pharmacology
container_volume 52
creator MUKERJI, MARK S.
LEATHARD, HELEN L.
HUDDART, HENRY
description The mechanisms underlying the suppression of vasocontractility caused by progesterone were investigated by studying changes in the contractile force of rat isolated aorta and portal vein, induced by altering extracellular concentrations of noradrenaline (NA) potassium ions (K+) and calcium ions (Ca2+). In the aorta, progesterone (10 μM) had a general suppressive effect on NA‐, Ca2+‐ and K+‐induced contractions. In contrast, in the portal vein a more selective suppression of contractions was observed. Both tonic and phasic components of contractions induced by cumulative addition of Ca2+ to tissues equilibrated in Ca2+‐free saline were suppressed. The phasic but not tonic components of contractions induced by NA addition were suppressed. There was no significant effect on tonic contractions induced by elevated (40–120 mM) K+, but a concentration‐dependent suppression of the phasic component of contractions was observed during depolarisation with smaller elevations of K+ concentrations (5–20 mM). These results suggest that on the portal vein the suppressive effect of progesterone is due to a potassium channel opening action, whilst on the aorta a different or additional mechanism of suppression exists.
doi_str_mv 10.1211/0022357001774525
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_20611907</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20611907</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4819-e5f574e6a289f20c6341b07bfbadc7dc1e1da802b567ae2d860d0d843a8a26fd3</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi1ERZfCnRPyAXFLGduxnRxXq6VLW5WIFpC4WI4_StpsvLWz0P77eskKEBdOtjTPM555jdArAseEEvIOgFLGJQCRsuSUP0EzCiUtJOHVUzTblYtcZ4foeUo3ACCFEM_QIYGaMcL4DN1cfXd46b0zIw4eNzFcuzS6GAaHw4AvN2EY9eDCNmE9WDy_DkOXxmL5I9w6ixe5GrUZuzCknT7mZp_0iOchjvqX0OxuPf7iuuEFOvC6T-7l_jxCn98vrxar4vzjyYfF_LwwZUXqwnHPZemEplXtKRjBStKCbH2rrZHWEEesroC2XEjtqK0EWLBVyXSlqfCWHaG3U99NDHfbvI1ad8m4vp_2UBQEITXIDMIEmhhSis6rTezWOj4oAmqXr_o336y83vfetmtn_xKmQDPwZg_oZHTvox5Ml_5wJdA8cMb4hP3sevfw33fVabNqJKmzV0xe_gR3_9vT8VYJySRXXy9OFFs0p5erb2eKs0emsqBM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20611907</pqid></control><display><type>article</type><title>The Effect of Progesterone on Spontaneous and Agonist-Evoked Contractions of the Rat Aorta and Portal Vein</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Wiley Online Library All Journals</source><creator>MUKERJI, MARK S. ; LEATHARD, HELEN L. ; HUDDART, HENRY</creator><creatorcontrib>MUKERJI, MARK S. ; LEATHARD, HELEN L. ; HUDDART, HENRY</creatorcontrib><description>The mechanisms underlying the suppression of vasocontractility caused by progesterone were investigated by studying changes in the contractile force of rat isolated aorta and portal vein, induced by altering extracellular concentrations of noradrenaline (NA) potassium ions (K+) and calcium ions (Ca2+). In the aorta, progesterone (10 μM) had a general suppressive effect on NA‐, Ca2+‐ and K+‐induced contractions. In contrast, in the portal vein a more selective suppression of contractions was observed. Both tonic and phasic components of contractions induced by cumulative addition of Ca2+ to tissues equilibrated in Ca2+‐free saline were suppressed. The phasic but not tonic components of contractions induced by NA addition were suppressed. There was no significant effect on tonic contractions induced by elevated (40–120 mM) K+, but a concentration‐dependent suppression of the phasic component of contractions was observed during depolarisation with smaller elevations of K+ concentrations (5–20 mM). These results suggest that on the portal vein the suppressive effect of progesterone is due to a potassium channel opening action, whilst on the aorta a different or additional mechanism of suppression exists.</description><identifier>ISSN: 0022-3573</identifier><identifier>EISSN: 2042-7158</identifier><identifier>DOI: 10.1211/0022357001774525</identifier><identifier>PMID: 10933135</identifier><identifier>CODEN: JPPMAB</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Animals ; Aorta - drug effects ; Biological and medical sciences ; Calcium - pharmacology ; Cardiovascular system ; Drug Interactions ; In Vitro Techniques ; Male ; Medical sciences ; Miscellaneous ; Norepinephrine - pharmacology ; Pharmacology. Drug treatments ; Portal Vein - drug effects ; Potassium - pharmacology ; Progesterone - pharmacology ; Rats ; Rats, Wistar ; Vasoconstriction - drug effects ; Vasoconstrictor Agents - pharmacology</subject><ispartof>Journal of pharmacy and pharmacology, 2000-07, Vol.52 (7), p.843-849</ispartof><rights>2000 Royal Pharmaceutical Society of Great Britain</rights><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4819-e5f574e6a289f20c6341b07bfbadc7dc1e1da802b567ae2d860d0d843a8a26fd3</citedby><cites>FETCH-LOGICAL-c4819-e5f574e6a289f20c6341b07bfbadc7dc1e1da802b567ae2d860d0d843a8a26fd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1211%2F0022357001774525$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1211%2F0022357001774525$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1402860$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10933135$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MUKERJI, MARK S.</creatorcontrib><creatorcontrib>LEATHARD, HELEN L.</creatorcontrib><creatorcontrib>HUDDART, HENRY</creatorcontrib><title>The Effect of Progesterone on Spontaneous and Agonist-Evoked Contractions of the Rat Aorta and Portal Vein</title><title>Journal of pharmacy and pharmacology</title><addtitle>J Pharm Pharmacol</addtitle><description>The mechanisms underlying the suppression of vasocontractility caused by progesterone were investigated by studying changes in the contractile force of rat isolated aorta and portal vein, induced by altering extracellular concentrations of noradrenaline (NA) potassium ions (K+) and calcium ions (Ca2+). In the aorta, progesterone (10 μM) had a general suppressive effect on NA‐, Ca2+‐ and K+‐induced contractions. In contrast, in the portal vein a more selective suppression of contractions was observed. Both tonic and phasic components of contractions induced by cumulative addition of Ca2+ to tissues equilibrated in Ca2+‐free saline were suppressed. The phasic but not tonic components of contractions induced by NA addition were suppressed. There was no significant effect on tonic contractions induced by elevated (40–120 mM) K+, but a concentration‐dependent suppression of the phasic component of contractions was observed during depolarisation with smaller elevations of K+ concentrations (5–20 mM). These results suggest that on the portal vein the suppressive effect of progesterone is due to a potassium channel opening action, whilst on the aorta a different or additional mechanism of suppression exists.</description><subject>Animals</subject><subject>Aorta - drug effects</subject><subject>Biological and medical sciences</subject><subject>Calcium - pharmacology</subject><subject>Cardiovascular system</subject><subject>Drug Interactions</subject><subject>In Vitro Techniques</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Norepinephrine - pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Portal Vein - drug effects</subject><subject>Potassium - pharmacology</subject><subject>Progesterone - pharmacology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Vasoconstriction - drug effects</subject><subject>Vasoconstrictor Agents - pharmacology</subject><issn>0022-3573</issn><issn>2042-7158</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1v1DAQhi1ERZfCnRPyAXFLGduxnRxXq6VLW5WIFpC4WI4_StpsvLWz0P77eskKEBdOtjTPM555jdArAseEEvIOgFLGJQCRsuSUP0EzCiUtJOHVUzTblYtcZ4foeUo3ACCFEM_QIYGaMcL4DN1cfXd46b0zIw4eNzFcuzS6GAaHw4AvN2EY9eDCNmE9WDy_DkOXxmL5I9w6ixe5GrUZuzCknT7mZp_0iOchjvqX0OxuPf7iuuEFOvC6T-7l_jxCn98vrxar4vzjyYfF_LwwZUXqwnHPZemEplXtKRjBStKCbH2rrZHWEEesroC2XEjtqK0EWLBVyXSlqfCWHaG3U99NDHfbvI1ad8m4vp_2UBQEITXIDMIEmhhSis6rTezWOj4oAmqXr_o336y83vfetmtn_xKmQDPwZg_oZHTvox5Ml_5wJdA8cMb4hP3sevfw33fVabNqJKmzV0xe_gR3_9vT8VYJySRXXy9OFFs0p5erb2eKs0emsqBM</recordid><startdate>200007</startdate><enddate>200007</enddate><creator>MUKERJI, MARK S.</creator><creator>LEATHARD, HELEN L.</creator><creator>HUDDART, HENRY</creator><general>Blackwell Publishing Ltd</general><general>Pharmaceutical Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope></search><sort><creationdate>200007</creationdate><title>The Effect of Progesterone on Spontaneous and Agonist-Evoked Contractions of the Rat Aorta and Portal Vein</title><author>MUKERJI, MARK S. ; LEATHARD, HELEN L. ; HUDDART, HENRY</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4819-e5f574e6a289f20c6341b07bfbadc7dc1e1da802b567ae2d860d0d843a8a26fd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Animals</topic><topic>Aorta - drug effects</topic><topic>Biological and medical sciences</topic><topic>Calcium - pharmacology</topic><topic>Cardiovascular system</topic><topic>Drug Interactions</topic><topic>In Vitro Techniques</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Norepinephrine - pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Portal Vein - drug effects</topic><topic>Potassium - pharmacology</topic><topic>Progesterone - pharmacology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Vasoconstriction - drug effects</topic><topic>Vasoconstrictor Agents - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MUKERJI, MARK S.</creatorcontrib><creatorcontrib>LEATHARD, HELEN L.</creatorcontrib><creatorcontrib>HUDDART, HENRY</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><jtitle>Journal of pharmacy and pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MUKERJI, MARK S.</au><au>LEATHARD, HELEN L.</au><au>HUDDART, HENRY</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Effect of Progesterone on Spontaneous and Agonist-Evoked Contractions of the Rat Aorta and Portal Vein</atitle><jtitle>Journal of pharmacy and pharmacology</jtitle><addtitle>J Pharm Pharmacol</addtitle><date>2000-07</date><risdate>2000</risdate><volume>52</volume><issue>7</issue><spage>843</spage><epage>849</epage><pages>843-849</pages><issn>0022-3573</issn><eissn>2042-7158</eissn><coden>JPPMAB</coden><abstract>The mechanisms underlying the suppression of vasocontractility caused by progesterone were investigated by studying changes in the contractile force of rat isolated aorta and portal vein, induced by altering extracellular concentrations of noradrenaline (NA) potassium ions (K+) and calcium ions (Ca2+). In the aorta, progesterone (10 μM) had a general suppressive effect on NA‐, Ca2+‐ and K+‐induced contractions. In contrast, in the portal vein a more selective suppression of contractions was observed. Both tonic and phasic components of contractions induced by cumulative addition of Ca2+ to tissues equilibrated in Ca2+‐free saline were suppressed. The phasic but not tonic components of contractions induced by NA addition were suppressed. There was no significant effect on tonic contractions induced by elevated (40–120 mM) K+, but a concentration‐dependent suppression of the phasic component of contractions was observed during depolarisation with smaller elevations of K+ concentrations (5–20 mM). These results suggest that on the portal vein the suppressive effect of progesterone is due to a potassium channel opening action, whilst on the aorta a different or additional mechanism of suppression exists.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>10933135</pmid><doi>10.1211/0022357001774525</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-3573
ispartof Journal of pharmacy and pharmacology, 2000-07, Vol.52 (7), p.843-849
issn 0022-3573
2042-7158
language eng
recordid cdi_proquest_miscellaneous_20611907
source MEDLINE; Oxford University Press Journals All Titles (1996-Current); Wiley Online Library All Journals
subjects Animals
Aorta - drug effects
Biological and medical sciences
Calcium - pharmacology
Cardiovascular system
Drug Interactions
In Vitro Techniques
Male
Medical sciences
Miscellaneous
Norepinephrine - pharmacology
Pharmacology. Drug treatments
Portal Vein - drug effects
Potassium - pharmacology
Progesterone - pharmacology
Rats
Rats, Wistar
Vasoconstriction - drug effects
Vasoconstrictor Agents - pharmacology
title The Effect of Progesterone on Spontaneous and Agonist-Evoked Contractions of the Rat Aorta and Portal Vein
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T02%3A27%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Effect%20of%20Progesterone%20on%20Spontaneous%20and%20Agonist-Evoked%20Contractions%20of%20the%20Rat%20Aorta%20and%20Portal%20Vein&rft.jtitle=Journal%20of%20pharmacy%20and%20pharmacology&rft.au=MUKERJI,%20MARK%20S.&rft.date=2000-07&rft.volume=52&rft.issue=7&rft.spage=843&rft.epage=849&rft.pages=843-849&rft.issn=0022-3573&rft.eissn=2042-7158&rft.coden=JPPMAB&rft_id=info:doi/10.1211/0022357001774525&rft_dat=%3Cproquest_cross%3E20611907%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20611907&rft_id=info:pmid/10933135&rfr_iscdi=true